Heba Elassar, MD

Clinical Instructor, Boston University Chobanian & Avedisian School of Medicine

Publications

  • Published 7/1/2025

    Ward KR, Elassar H, Pastewski J, Lapkus M, Studzinski D, Sun F, Reilly J, Czako P, Nagar S. Incidence and Risk of Second Primary Malignancies After Treatment for Papillary Thyroid Cancer: A Single Institution Study. Am J Clin Oncol. 2025 Jul 01. PMID: 40590273.

    Read at: PubMed

  • Published 11/27/2024

    Odil EE, Ward KR, Davis RT, Reilly JM, Sun F, Elassar H, Lapkus M, Pastewski J, Studzinski DM, Callahan RE, Czako PF, Nagar S. Radioactive iodine therapy dose impact on recurrence and survival in N1 papillary thyroid cancer. Nucl Med Commun. 2025 Feb 01; 46(2):113-119. PMID: 39604284.

    Read at: PubMed

  • Published 12/9/2021

    Reilly J, Faridmoayer E, Lapkus M, Pastewski J, Sun F, Elassar H, Studzinski DM, Callahan RE, Czako P, Nagar S. Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma. Am J Surg. 2022 Mar; 223(3):487-491. PMID: 34952686.

    Read at: PubMed

  • Published 11/20/2021

    Giovanatti A, Elassar H, Karabon P, Wunderlich-Barillas T, Halalau A. Social Determinants of Health Correlating with Mechanical Ventilation of COVID-19 Patients: A Multi-Center Observational Study. Int J Gen Med. 2021; 14:8521-8526. PMID: 34848998.

    Read at: PubMed

  • Published 6/9/2020

    Imam Z, Odish F, Armstrong J, Elassar H, Dokter J, Langnas E, Halalau A. Independent Correlates of Hospitalization in 2040 Patients with COVID-19 at a Large Hospital System in Michigan, United States. J Gen Intern Med. 2020 Aug; 35(8):2516-2517. PMID: 32519326.

    Read at: PubMed

Websites